Halo Collective Inc.
Halo Collective Inc.
Your view on HALO.NE
Overview
What the company does, where it operates, and who runs it.
About Halo Collective Inc.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Katharyn Field
- Headquarters
- CA
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Katharyn Field
- Headquarters
- CA
Halo Collective Inc. operates as a cannabis cultivation, manufacturing, and distribution company that grows, extracts, and processes cannabis flower, oils, and concentrates in the United States. It also offers edible products, including cannabis-infused gummies and a syrup-based drink in California and Oregon.
In addition, the company markets branded and private label products. It sells its cannabis products principally to dispensaries under Hush, Mojave, and Exhale brands. The company serves licensed retailers and wholesalers. It has a strategic partnership with High Tide Inc; and with OG DNA Genetics Inc to develop genetics in Oregon.
The company was formerly known as Halo Labs Inc. and changed its name to Halo Collective Inc. in January 2021. Halo Collective Inc. was founded in 2016 and is headquartered in Toronto, Canada.
Past Reports
Historical coverage archive.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Halo Collective Inc.. Starting points for Halo Collective Inc.: beta 1.66 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Halo Collective Inc.. Halo Collective Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Halo Collective Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Halo Collective Inc.. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| ULIHFThe United Laboratories International Holdings Limited | Healthcare | OTC | $3.2B | ||
| UPCUniverse Pharmaceuticals Inc. | Healthcare | NASDAQ | $961,098 | ||
| USMJNorth American Cannabis Holdings, Inc. | Healthcare | OTC | $137,858 | ||
| VDRMViaDerma, Inc. | Healthcare | OTC | $493,484 | ||
| VENI.CNVencanna Ventures Inc. | Healthcare | CNQ | $1.1M | ||
| VEXT.CNVext Science, Inc. | Healthcare | CNQ | $59.5M | ||
| VEXTFVext Science, Inc. | Healthcare | OTC | $43.8M | ||
| VIBE.CNVibe Growth Corporation | Healthcare | CNQ | $647,819 | ||
| VIBEFVibe Growth Corporation | Healthcare | OTC | $431,880 | ||
| VIT.AXVitura Health Limited | Healthcare | ASX | — | ||
| VIVXFAvivagen Inc. | Healthcare | OTC | $7,769 | ||
| VLS.AXVita Life Sciences Limited | Healthcare | ASX | — | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Halo Collective Inc.. Coverage tracks Halo Collective Inc. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Halo Collective Inc.